Yoshihiro Ohmori

4PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersOrthodontics and dentofacial orthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 23, 2023
Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line.

Ari Matsumoto, Miki Hiroi, Kazumasa Mori

|Apr 23, 2022
Enhanced Cytotoxic Effects in Human Oral Squamous Cell Carcinoma Cells Treated with Combined Methyltransferase Inhibitors and Histone Deacetylase Inhibitors.

Ryosuke Ushio, Miki Hiroi, Ari Matsumoto

|Apr 30, 2021
Simultaneous Expression of Th1- and Treg-Associated Chemokine Genes and CD4+, CD8+, and Foxp3+ Cells in the Premalignant Lesions of 4NQO-Induced Mouse Tongue Tumorigenesis.

Hana Yamaguchi, Miki Hiroi, Kazumasa Mori

|Aug 31, 2018
Costimulation of Murine Osteoblasts with Interferon-γ and Tumor Necrosis Factor-α Induces Apoptosis through Downregulation of Bcl-2 and Release of Cytochrome c from Mitochondria.

Mayumi Iguchi, Miki Hiroi, Haruhide Kanegae

Pageof 1

Frequent Collaborators